WS (WS)

$1.4B
Market Cap
12.0
P/E Ratio
1.59
Beta
2.28%
Dividend Yield
Piotroski 4/9Altman Z 3.3 SafeBeneish M -2.88 CleanROIC−WACC -5.3%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 3.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency for WS is currently strained, evidenced by an ROIC of 9.2% that falls significantly short of the 14.5% cost of equity, resulting in a negative spread of -5.3%. This indicates value destruction where returns on deployed capital fail to cover the hurdle rate required by shareholders. While the DuPont components are not explicitly detailed beyond margin and growth figures, the net margin compression at 3.6% coincides with revenue contraction of -9.8%, suggesting operational headwinds rather than a leverage-driven ROE boost. Credit quality metrics present a mixed signal; an Altman Z-Score of 3.3 places the firm in the "grey zone" between safety and distress, yet the Beneish M-Score of -2.88 strongly suggests low earnings manipulation risk, which may support underlying asset integrity despite deteriorating fundamentals.

Valuation multiples reflect market skepticism regarding future trajectory, with a current P/E of 12.0x likely priced against the backdrop of negative revenue growth and capital inefficiency. Although this multiple appears compressed relative to historical norms for profitable firms, it must be viewed through the lens of the DCF fair value estimate of $42, which implies that current market pricing may not fully account for potential mean reversion in margins or a stabilization in top-line performance if leverage is adjusted favorably. The disconnect between the negative ROIC-WACC spread and the available valuation discount suggests the stock carries significant downside risk absent a structural turnaround in operating efficiency.

Risk assessment highlights a precarious balance sheet profile given the Altman Z-Score proximity to distress thresholds, even as insider activity data remains unspecified in this dataset. The combination of shrinking revenues and capital destruction creates a high-beta environment where traditional value metrics may lag until operational leverage improves or debt levels are optimized. Investors must weigh whether the low Beneish M-Score provides sufficient confidence in reported earnings quality enough to justify holding through the current period of negative spread, or if the fundamental deterioration warrants caution regardless of valuation attractiveness.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →12.5%14.5%16.5%
2%$48$39$33
3%$52$42$35
4%$56$45$37

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=14.5%, terminal growth 3%. Fair value $42 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
3.3
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.88
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

12.6%
Gross Margin
3.6%
Net Margin
9.2%
ROIC
14.5%
WACC
ROIC − WACC Spread: -5.3%— Negative spread.
-9.8%
Revenue Growth (YoY)
-28.4%
Earnings Growth (YoY)
99.9M
Free Cash Flow
32%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.64x
Debt / Equity
1.66x
Current Ratio
21.9x
Interest Coverage
-0.2x
Net Debt / EBITDA
7.11%
FCF Yield
221.2M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.83
Act: $1.05
+26.5%
Q3
✓ Beat
Est: $0.72
Act: $0.77
+6.9%
Q2
✗ Miss
Est: $0.39
Act: $0.38
-2.6%
Q1
✗ Miss
Est: $0.47
Act: $0.27
-42.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

10.8
Forward P/E
PEG Ratio
1.28
Price/Book
286735
Avg Volume
$49.17
52W High
$21.30
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$57M
Tracked Passive Exposure
5
ETFs Holding WS
0.15%
Avg Weight in ETFs
$38B
Total ETF AUM

When investors buy or sell ETFs like XME or SLYV, the fund manager is mechanically forced to buy or sell WS shares regardless of WS's individual fundamentals. We estimate $57M of passive capital is structurally linked to WS through 5 tracked ETFs. Passive flows have a limited but growing influence on WS's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 5 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in WS to visualize passive redemption contagion across ETFs and collateral stocks.

WS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
WSEpicenterSPSMETFSPTMETFVAWETFLINLow RiskNEMLow RiskNVDALow RiskAAPLLow RiskNUELow Risk
WS Price Drop (%)0

If WS (WS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Linde plc (LIN) as the most exposed collateral stock, sharing 1 ETFs with WS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 5 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

WS Ownership Dynamics

Ticker
WS

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

WS Capital Efficiency

How efficiently does WS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$100M
EBITDA
$221M
FCF Conversion
45%
Reinvestment Rate
55%
45% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
9.2%
ROIC − WACC Spread
-5.3%

WS converts 45% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 55% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-5.3%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-089,920$40.43$401,065.6
2026-04-305$36.40$182
2026-04-281,632$37.71$61,542.72
2026-04-09865$33.51$28,986.15
2026-03-13901$32.68$29,444.68
2026-03-05257$39.08$10,043.56
2026-02-20950$43.56$41,382
2026-02-193$43.98$131.94
2026-02-0658$45.83$2,658.14
2026-02-042,792$44.41$123,992.72
2026-01-271,550$38.72$60,016
2026-01-0263$34.62$2,181.06
2025-12-3131$35.45$1,098.95
2025-12-161,632$35.45$57,854.4
2025-12-041,197$36.43$43,606.71
2025-12-01640$33.75$21,600
2025-11-175,352$31.67$169,497.84
2025-11-1410,458$31.77$332,250.66
2025-11-0668$31.68$2,154.24

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare WS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.